NovoCure Ltd.
(NASDAQ : NVCR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp. -0.34%265.520.7%$613.38m
TMOThermo Fisher Scientific, Inc. 0.14%521.001.0%$590.41m
MDTMedtronic Plc -0.99%82.730.6%$545.15m
ABTAbbott Laboratories -0.32%100.750.8%$528.64m
ISRGIntuitive Surgical, Inc. -0.29%190.520.8%$345.03m
SYKStryker Corp. -0.91%206.981.3%$289.15m
BSXBoston Scientific Corp. -1.02%38.901.0%$254.76m
BDXBecton, Dickinson & Co. -1.32%234.061.0%$240.65m
EWEdwards Lifesciences Corp. 0.71%84.770.4%$238.81m
DXCMDexCom, Inc. -0.37%80.661.9%$189.15m
AAgilent Technologies, Inc. -0.73%123.481.7%$183.21m
IDXXIDEXX Laboratories, Inc. 2.49%334.203.9%$173.71m
ALGNAlign Technology, Inc. 2.06%222.436.4%$172.49m
BAXBaxter International, Inc. 0.11%55.431.8%$166.03m
NEOGNeogen Corp. -1.20%14.790.5%$151.45m

Company Profile

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.